Curcumin-Loaded Nanoparticles Inhibit HIV-1 Replication
Author Information
Author(s): Gandapu Upendhar, Chaitanya R. K., Kishore Golla, Reddy Raju C., Kondapi Anand K.
Primary Institution: University of Hyderabad
Hypothesis
Can curcumin-loaded apotransferrin nanoparticles enhance the bioavailability and efficacy of curcumin in inhibiting HIV-1 replication?
Conclusion
Curcumin-loaded apotransferrin nanoparticles are highly effective at inhibiting HIV-1 replication in vitro and have potential for clinical use.
Supporting Evidence
- Nano-curcumin showed higher anti-HIV activity compared to soluble curcumin.
- Nano-curcumin was less toxic to cells than soluble curcumin at equivalent doses.
- The formulation enhanced cellular uptake of curcumin through transferrin receptor-mediated endocytosis.
Takeaway
Researchers created tiny particles that carry curcumin, a natural compound, to help fight HIV. These particles work better than curcumin alone and are less harmful to cells.
Methodology
Curcumin-loaded apotransferrin nanoparticles were prepared and characterized, followed by in vitro studies on their cellular uptake and anti-HIV activity.
Limitations
The study was conducted in vitro, and further in vivo studies are needed to confirm the findings.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website